1. Home
  2. MCK vs VRTX Comparison

MCK vs VRTX Comparison

Compare MCK & VRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo McKesson Corporation

MCK

McKesson Corporation

SELL

Current Price

$1,091.18

Market Cap

115.8B

Sector

Health Care

ML Signal

SELL

Logo Vertex Pharmaceuticals Incorporated

VRTX

Vertex Pharmaceuticals Incorporated

SELL

Current Price

$534.26

Market Cap

135.6B

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
MCK
VRTX
Founded
1833
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Other Pharmaceuticals
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
115.8B
135.6B
IPO Year
1995
2006

Fundamental Metrics

Financial Performance
Metric
MCK
VRTX
Price
$1,091.18
$534.26
Analyst Decision
Buy
Buy
Analyst Count
16
32
Target Price
★ $1,144.29
$595.36
AVG Volume (30 Days)
633.6K
★ 1.4M
Earning Date
11-04-2026
11-02-2026
Dividend Yield
★ 0.34%
N/A
EPS Growth
49.22
★ 836.54
EPS
★ 15.53
10.90
Revenue
★ $112,084,000,000.00
$2,488,652,000.00
Revenue This Year
$7.94
$10.46
Revenue Next Year
$6.87
$10.53
P/E Ratio
$71.16
★ $49.34
Revenue Growth
3.11
★ 46.20
52 Week Low
$723.68
$412.27
52 Week High
$1,121.50
$568.67

Technical Indicators

Market Signals
Indicator
MCK
VRTX
Relative Strength Index (RSI) 68.27 49.75
Support Level $835.39 $493.75
Resistance Level $1,121.50 $536.58
Average True Range (ATR) 25.91 16.14
MACD 3.20 -1.47
Stochastic Oscillator 78.91 14.27

Price Performance

Historical Comparison
MCK
VRTX

About MCK McKesson Corporation

McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex is focused on diversifying its portfolio through Casgevy (gene-editing therapy for beta thalassemia and sickle-cell disease), Journavx (non-opioid pain drug for moderate-to-severe acute pain), and Palsonify (for acromegaly). Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases, cell therapies to deliver a functional cure for type 1 diabetes, povetacicept (for IgA nephropathy).

Share on Social Networks: